VAERS reports by lot

GSK Varicella/Shingles lot EY93J: VAERS reports

56 VAERS reports list lot EY93J as a GSK Varicella/Shingles vaccine, received between 2018-10-17 and 2021-05-10. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
56
Reports
5%
Marked serious
0
With a death outcome
11
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)4723%
Injection-site / Local reaction4623%
Musculoskeletal3417%
Dermatological (non-injection-site)2412%
Neurological2211%
Allergic / Anaphylactic126%
Cardiac / Cardiovascular84%
Respiratory31%
Gastrointestinal31%
Psychiatric / Neuropsychiatric31%
Thrombotic / Hematological10%

Where reports came from

U.S. state of the reporter, where given (top 12).

New York9
Pennsylvania4
California4
Massachusetts4
Ohio4
North Carolina3
Alabama2
Michigan2
Connecticut2
New Jersey2
Wyoming2
Georgia2

Reports by month received

2018-1010
2018-1122
2018-127
2019-014
2019-023
2019-033
2019-042
2019-051
2019-061
2021-031
2021-052

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.